PROVECTUS BIOPHARMACEUTICALS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Provectus Biopharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 43.3 %, a 4.27% decline year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Return On Equity for 2023 was 42.2 %, a 27.9% decline from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Return On Equity for 2022 was 58.5 %, a 9.22% increase from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Return On Equity for 2021 was 53.6 %, a 125% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 42.2 -16.3 -27.9% Jan 1, 2023 Dec 31, 2023
2022 58.5 +4.94 +9.22% Jan 1, 2022 Dec 31, 2022
2021 53.6 +29.8 +125% Jan 1, 2021 Dec 31, 2021
2020 23.8 -8.25 -25.8% Jan 1, 2020 Dec 31, 2020
2019 32 -23.3 -42.1% Jan 1, 2019 Dec 31, 2019
2018 55.4 -185 -77% Jan 1, 2018 Dec 31, 2018
2017 241 +545 Jan 1, 2017 Dec 31, 2017
2016 -304 -199 -188% Jan 1, 2016 Dec 31, 2016
2015 -106 -53.9 -104% Jan 1, 2015 Dec 31, 2015
2014 -51.7 +356 +87.3% Jan 1, 2014 Dec 31, 2014
2013 -408 -142 -53.1% Jan 1, 2013 Dec 31, 2013
2012 -266 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.